MARATTO

article · Research and Practice in Thrombosis and Haemostasis

Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study

2024Open accessAin Shams University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Hemophilia Treatment and Research
  • Platelet Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.rpth.2024.102595

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.